Sertindole Terminated Phase 3 Trials for Psychosomatic Disorders / Depression / Dementia / Anxiety Disorders / Schizophrenia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric Patients